Analysis and Characterization of Trauma-Induced Coagulopathy
Analysis and Characterization of Trauma-Induced Coagulopathy
批准号:
9986376
负责人:
James H. Morrissey
金额:
$177.78万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-01 至 2020-05-31
关键词:
AddressAdultAnimal ModelBasic ScienceBloodBlood CellsBlood Coagulation DisordersBlood VesselsBlood specimenCause of DeathCellsClinicalClinical DataClinical ResearchClinical TrialsCoagulation ProcessCollectionComplexCultured CellsDepartment of DefenseDiagnosisEnsureEvaluationEventExposure toFactor VaFibrinogenFundingGoalsHemorrhageHemostatic AgentsHormonesImmune responseIn VitroInflammationInflammatoryInflammatory ResponseInfrastructureInjuryLaboratoriesLeadLipidsLogisticsMediatingMediator of activation proteinMethodsMolecularMorbidity - disease rateMorphologic artifactsNatural HistoryPatientsPeptide HydrolasesPlasmaPlasma ProteinsProcessProductivityProteinsProteolysisResearchResearch PersonnelResearch Project GrantsResource AllocationSamplingSecureSelection for TreatmentsShipsShockSiteSyndromeSystemSystems BiologyTechniquesTechnologyTherapeutic InterventionTissuesTranslatingTranslational ResearchTranslationsTraumaTrauma patientTraumatic injuryVascular EndotheliumVenous blood samplingactivated Protein Cbiobankcell injuryclinically relevantcofactorcytokineexhaustexperienceimprovedin vivomembermortalitymultidisciplinarynew technologynovelpoint of carepreventprogramsrepositoryresource guidestrauma centers
中文摘要
点击翻译按钮获取中文摘要
英文摘要
OVERALL:
Uncontrolled hemorrhage is the major cause of death in adults exposed to severe trauma. Trauma-induced
coagulopathy (TIC) occurs after injury and shock, accompanied by a “storm” of inflammatory and coagulation
events leading to incapacitation of the hemostatic process. TIC compromises the hemostatic system because
of dysregulated processes occurring on a systemic basis in which proteolytic systems destroy essential
coagulation components. Previous studies have identified activated protein C-mediated destruction of the
cofactor factor Va and implicated systemic fibrinolytic activity in which unregulated proteolysis destroys
fibrinogen and parts of the plasma coagulation system. These terminal events observed in phlebotomy blood of
TIC patients are caused by in vivo processes involving the proteins, cells and cytokines in blood and vascular
tissues and tissue damage material entering the blood. The causes and breadth of TIC are not understood.
This TACTIC project provides a comprehensive evaluation of the contributions of plasma proteins, blood cells,
the vascular endothelium, the blood vessel, and extravascular tissue to TIC, making use of a unique
infrastructure that includes already-funded DoD sites involved in trauma trials and Systems Biology. A
comprehensive team approach by leading investigators in coagulation and inflammation research addresses
the problem using a composite of in vitro and in vivo approaches to identify candidates responsible for TlC.
Early translation of laboratory results into useful technology will be enabled by a set of 5 TACTIC trauma
centers. Simultaneous with these studies, interactions with clinical centers engaged in DoD clinical trials will be
developed in which research personnel at each center will be responsible for point-of-care studies and
processing of blood samples. Collection techniques will utilize inhibitory cocktails to block ex vivo, post-
phlebotomy artifacts. Blood/plasma samples will be shipped to a secure repository and analyzed utilizing new
technology to identify the natural history of TIC events. Continuation of TACTIC research projects will be
dependent upon their potential utility for diagnosis and selection of therapy for trauma patients.
Summaries for the Coagulation, Inflammation and Coordinating Center remain unchanged from the original
submission.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1097/mbc.0000000000001089
发表时间:
2022-01-01
期刊:
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
影响因子:
--
作者:
[Plautz WE, Haldeman SH, Dyer MR, Sperry JL, Guyette FX, Loughran PA, Alvikas J, Hassoune A, Hoteit L, Alsaadi N, Zuckerbraun BS, Rollins-Raval MA, Raval JS, Mota RI, Neal MD, A TACTIC Publication]
通讯作者:
A TACTIC Publication
DOI:
10.1371/journal.pone.0270817
发表时间:
2022
期刊:
PloS one
影响因子:
3.7
作者:
[]
通讯作者:
DOI:
10.1111/jth.15455
发表时间:
2021-09
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
作者:
[Hollerbach A, Müller-Calleja N, Pedrosa D, Canisius A, Sprinzl MF, Falter T, Rossmann H, Bodenstein M, Werner C, Sagoschen I, Münzel T, Schreiner O, Sivanathan V, Reuter M, Niermann J, Galle PR, Teyton L, Ruf W, Lackner KJ]
通讯作者:
Lackner KJ
Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
烧伤患者因子XIa、因子IXa及组织因子活性分析
DOI:
10.1016/j.burns.2017.08.003
发表时间:
2018
期刊:
Burns : journal of the International Society for Burn Injuries
影响因子:
--
作者:
[Shupp,JeffreyW, Prior,ShannonM, Jo,DanielY, Moffatt,LaurenT, Mann,KennethG, Butenas,Saulius]
通讯作者:
Butenas,Saulius
Packed Red Blood Cells Accumulate Oxidative Stress With Increased Storage Duration.
随着储存时间的增加,浓缩红细胞会积累氧化应激。
DOI:
10.1097/shk.0000000000000828
发表时间:
2017
期刊:
Shock (Augusta, Ga.)
影响因子:
--
作者:
[Preston,Kelsey, Harm,Sarah, Dreyfus,Nathan, Villalba,Nuria, Freeman,Kalev]
通讯作者:
Freeman,Kalev
共 24 条
Mechanisms in Blood Clotting
-
批准号:9553003
-
项目类别:
-
资助金额:$39.81万
-
财政年份:2017
-
负责人:James H. Morrissey
-
依托单位:
Mechanisms in Blood Clotting
-
批准号:10594476
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2017
-
负责人:James H. Morrissey
-
依托单位:
Mechanisms in Blood Clotting
-
批准号:9244452
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2017
-
负责人:James H. Morrissey
-
依托单位:
Mechanisms in Blood Clotting
-
批准号:10383661
-
项目类别:
-
资助金额:$67.73万
-
财政年份:2017
-
负责人:James H. Morrissey
-
依托单位:
Toolkit for High-Resolution Structure and Dynamics of Functional Lipids
-
批准号:9352363
-
项目类别:
-
资助金额:$95.51万
-
财政年份:2016
-
负责人:James H. Morrissey
-
依托单位:
Toolkit for High-Resolution Structure and Dynamics of Functional Lipids
-
批准号:9752610
-
项目类别:
-
资助金额:$95.51万
-
财政年份:2016
-
负责人:James H. Morrissey
-
依托单位:
Structure and Function of Protein-Membrane Interactions in Blood Clotting
-
批准号:8644862
-
项目类别:
-
资助金额:$53.29万
-
财政年份:2010
-
负责人:James H. Morrissey
-
依托单位:
Structure and Function of Protein-Membrane Interactions in Blood Clotting
-
批准号:8450177
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2010
-
负责人:James H. Morrissey
-
依托单位:
Structure and Function of Protein-Membrane Interactions in Blood Clotting
-
批准号:8244432
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2010
-
负责人:James H. Morrissey
-
依托单位:
Structure and Function of Protein-Membrane Interactions in Blood Clotting
-
批准号:8106190
-
项目类别:
-
资助金额:$54.38万
-
财政年份:2010
-
负责人:James H. Morrissey
-
依托单位:
Structure and Function of Protein-Membrane Interactions in Blood Clotting
-
批准号:7947102
-
项目类别:
-
资助金额:$63.34万
-
财政年份:2010
-
负责人:James H. Morrissey
-
依托单位:
FACTOR VIIa IN COAGULATION/THROMBOSIS
-
批准号:6866592
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2004
-
负责人:James H. Morrissey
-
依托单位:
CORE--ASSAY
-
批准号:6866595
-
项目类别:
-
资助金额:$2.92万
-
财政年份:2004
-
负责人:James H. Morrissey
-
依托单位:
CORE--ASSAY
-
批准号:6302365
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2000
-
负责人:James H. Morrissey
-
依托单位:
FACTOR VIIA IN COAGULATION/THROMBOSIS
-
批准号:6302362
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2000
-
负责人:James H. Morrissey
-
依托单位:
FACTOR VIIA IN COAGULATION/THROMBOSIS
-
批准号:6110490
-
项目类别:
-
资助金额:$22.97万
-
财政年份:1999
-
负责人:James H. Morrissey
-
依托单位:
CORE--ASSAY
-
批准号:6110493
-
项目类别:
-
资助金额:$22.97万
-
财政年份:1999
-
负责人:James H. Morrissey
-
依托单位:
CORE--ASSAY
-
批准号:6273077
-
项目类别:
-
资助金额:$22.16万
-
财政年份:1998
-
负责人:James H. Morrissey
-
依托单位:
FACTOR VIIA IN COAGULATION/THROMBOSIS
-
批准号:6273074
-
项目类别:
-
资助金额:$22.16万
-
财政年份:1998
-
负责人:James H. Morrissey
-
依托单位:
FACTOR VIIA IN COAGULATION/THROMBOSIS
-
批准号:6242484
-
项目类别:
-
资助金额:$22.4万
-
财政年份:1997
-
负责人:James H. Morrissey
-
依托单位:
海外基金